Word: tumors
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Groopman’s retelling, the sixth doctor saves the day by questioning the simple diagnosis, discovering that the symptoms were the result of an unlikely culprit: a tumor...
...Through her marathon run, MacCarthy raised more than $4,000 for the Brain Tumor Society...
...cancer vaccine is not like the measles shot you get as a kid. Instead of inoculating a healthy person against a foreign body like a virus, cancer vaccines use parts of tumors to help the patients' immune systems recognize diseased cells. Follicular lymphoma, a generally slow-moving cancer of the immune system that affects roughly 5,000 Spaniards each year, presents an especially enticing target for vaccine researchers because its cells all carry a protein, called an idiotype, that distinguishes them from their healthy counterparts. Mixing the idiotype with other substances that trigger immunological responses, "the vaccine presents a tumor...
...whom Bendandi refers are the nine scientists on his team at work on customized cancer vaccines. A treatment that uses a patient's own tumor cells to provoke an immunological response, vaccines are one of the most promising developments in the fight against cancer, and a goal hotly pursued by researchers around the world. Bendandi and his colleagues at Spain's Center for Applied Medical Research and the University of Navarre Hospital have gone farther than most. In a five-year-long study - its results were described as "remarkable" by the Journal of the National Cancer Institute which published...
...create a vaccine for humans that would trigger an immune response. In 1999 Kwak, then working at the National Institutes of Health (nih), modified the vaccine in a way that makes it easier for the immune system to recognize. His results were striking: the vaccine eliminated the residual tumor cells left after chemotherapy in 15 of his 20 patients. Now Bendandi, who worked with Kwak at the nih, has erected what he calls "the third pillar" of customized therapy by demonstrating that the vaccine produces not just molecular benefits, but clinical ones as well. In other words, the patients...